NCT02152982 2026-04-13
Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
National Cancer Institute (NCI)
Phase 2/3 Active not recruiting
Clinical Trials
46 trialsNCT03970447 2026-04-08
GBM AGILE
Global Coalition for Adaptive Research
Phase 2/3 Recruiting
NCT07440290 2026-02-27
DETERMINE
Cancer Research UK
Phase 2/3 Not yet recruiting
NCT06105619 2026-01-20
A Study of PLB1001 Enteric Capsules in the Treatment of sGBM/IDH Mutant Glioblastoma Patients With the ZM Fusion Gene (FUGEN).
Beijing Pearl Biotechnology Limited Liability Company
Phase 2/3 Active not recruiting
NCT07349693 2026-01-20
Cerebraca-02/3
Everfront Biotech Co., Ltd.
Phase 2/3 Not yet recruiting
NCT05669820 2026-01-09
AFGB2
Skane University Hospital
Phase 2/3 Recruiting
NCT02066220 2025-12-04
International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma
Universitätsklinikum Hamburg-Eppendorf
Phase 2/3 Active not recruiting
NCT05768178 2025-11-24
DETERMINE
Cancer Research UK
Phase 2/3 Recruiting
NCT05770037 2025-11-24
DETERMINE
Cancer Research UK
Phase 2/3 Recruiting
NCT05770544 2025-11-24
DETERMINE
Cancer Research UK
Phase 2/3 Recruiting
NCT06988475 2025-11-24
DETERMINE
Cancer Research UK
Phase 2/3 Recruiting
NCT04250922 2025-11-20
CLINGLIO
Laminar Pharmaceuticals
Phase 2/3 Active not recruiting
NCT05130866 2025-10-07
POPLAR-NF2
Recursion Pharmaceuticals Inc.
Phase 2/3 Terminated
NCT03653546 2025-09-10
BM
Alpha Biopharma (Jiangsu) Co., Ltd.
Phase 2/3 Completed
NCT05807893 2024-11-13
SUPER BRAIN
Sun Yat-sen University
Phase 2/3 Completed
NCT00003375 2024-07-09
Observation or Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Low-Grade Glioma
Radiation Therapy Oncology Group
Phase 2/3 Completed
NCT03579602 2024-06-27
Study of Tozuleristide and the Canvas Imaging System in Pediatric Subjects With CNS Tumors Undergoing Surgery
Blaze Bioscience Inc.
Phase 2/3 Completed
NCT03548571 2024-04-03
DEN-STEM
Oslo University Hospital
Phase 2/3 Recruiting
NCT01236560 2024-02-20
Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma
National Cancer Institute (NCI)
Phase 2/3 Completed
NCT03275402 2024-02-13
131I-omburtamab Radioimmunotherapy for Neuroblastoma Central Nervous System/Leptomeningeal Metastases
Y-mAbs Therapeutics
Phase 2/3 Terminated
NCT05096468 2023-07-06
Esketamine Combined With Pregabalin on Acute Postoperative Pain in Patients Undergoing Resection of Spinal Neoplasms.
Beijing Tiantan Hospital
Phase 2/3 Completed
NCT02879682 2023-06-01
Motorstim
Technical University of Munich
Phase 2/3 Completed
NCT02448992 2023-05-01
Hippocampal-Sparing Prophylactic Cranial Irradiation in Pathologically Nodal Positive Non-Small-Cell Lung Cancer
Chang Gung Memorial Hospital
Phase 2/3 Recruiting
NCT03534050 2023-05-01
Neuropsychological and Oncological Outcomes in Grade 2 or 3 Glioma Patients Undergoing Postoperative Modern Radiotherapy
Chang Gung Memorial Hospital
Phase 2/3 Recruiting
NCT00442533 2023-04-03
Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine Tumors
Radio Isotope Therapy of America
Phase 2/3 Completed
NCT02881957 2022-06-15
Hypovitaminosis D in Neurocritical Patients
University of Utah
Phase 2/3 Completed
NCT03008148 2021-05-11
Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM
Johnpro Biotech, Inc.
Phase 2/3 Unknown
NCT03025893 2021-04-19
STELLAR
Amsterdam UMC, location VUmc
Phase 2/3 Unknown
NCT02678975 2021-03-18
Disulfiram in Recurrent Glioblastoma
Sahlgrenska University Hospital
Phase 2/3 Completed
NCT02256124 2020-04-14
NF1-EXCEL
Erasmus Medical Center
Phase 2/3 Terminated
NCT04105374 2020-03-24
Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma
NRG Oncology
Phase 2/3 Withdrawn
NCT02414165 2020-02-07
Toca5
Tocagen Inc.
Phase 2/3 Terminated
NCT00539500 2019-07-26
Autologous Stem Cell Rescue With CD133+ Selected Cells in High-Risk Neuroblastoma
M.D. Anderson Cancer Center
Phase 2/3 Terminated
NCT00749723 2018-07-20
HIT-REZ-2005
University Hospital, Bonn
Phase 2/3 Completed
NCT01759810 2017-10-12
Proteome-based Personalized Immunotherapy of Glioblastoma
NeuroVita Clinic
Phase 2/3 Unknown
NCT01782274 2017-10-12
Proteome-based Immunotherapy of Brain Metastases From Breast Cancer
NeuroVita Clinic
Phase 2/3 Unknown
NCT01782287 2017-10-12
Proteome-based Immunotherapy of Lung Cancer Brain Metastases
NeuroVita Clinic
Phase 2/3 Unknown
NCT00002533 2016-12-15
Fluconazole in Preventing Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer
University of Miami
Phase 2/3 Completed
NCT01961934 2016-09-28
C11-Sodium Acetate PET/CT Imaging Evaluation in Brain Glioma, Post Therapy Necrosis and Pseudo-progression
Phoenix Molecular Imaging
Phase 2/3 Withdrawn
NCT00123760 2016-02-25
Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer
AHS Cancer Control Alberta
Phase 2/3 Completed
NCT02338011 2015-01-26
EGFR
Shanghai Chest Hospital
Phase 2/3 Unknown
NCT01460706 2013-12-12
DOTAGLI
Turku University Hospital
Phase 2/3 Completed
NCT01813240 2013-03-18
Prevention of Imminent Paralysis Following Spinal Cord Trauma or Ischemia by Minocycline: A Multi-center Study in Israel With IDF Primary Care Involvement
Hadassah Medical Organization
Phase 2/3 Unknown
NCT00427583 2012-08-07
Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors
Novartis
Phase 2/3 Terminated
NCT00921037 2011-07-13
First Clinical Study of Erbium - Yttrium Aluminium Garnet (YAG) Laser Vaporization of Cutaneous Neurofibromas
Medical University of Vienna
Phase 2/3 Unknown
NCT01308632 2011-03-04
Metronomic Temozolamide in Patients With Recurrent Glioblastoma
Grupo Español de Investigación en Neurooncología
Phase 2/3 Unknown